Clinical Trial Center

What Clinical Trial Center does

Clinical Trial Center (CTC) is an independent, full-service Contract Research Organization founded in 2005 in Timisoara, Romania, by Beniamin Tăbăcaru, MD, who continues to serve as CEO. The company delivers clinical trial services to international pharmaceutical, medical devices, and biotechnology sponsors, operating across a broad therapeutic footprint that includes Pneumology, Cardiology, Nephrology, Neurology, Diabetes, Oncology, Hematology, Psychiatry, Dermatology, Gastroenterology, and Genetic Diseases. CTC has conducted more than 150 clinical trials over 15 years, spanning Phase I through Phase III and non-interventional studies, with a notable breakdown of 6 Phase I, 32 Phase II, and 59 Phase III protocols.

CTC operates a modular service architecture covering Project Management, GCP Training, Investigator Meeting Organization, Flying Nurse Services, Clinical Monitoring, Regulatory Affairs (submissions to Romania's National Medicines and Medical Devices Agency and Ethics Committee), Auditing, Biometrics and Medical Biostatistics, Data Management, and Certified Translations between English and Romanian. Clinical monitoring is performed in accordance with ICH-GCP, EU Directives, and FDA regulations. Service delivery is supported by a national investigator network of 40 county hospitals, 12 university hospitals, 53 city hospitals, approximately 1,000 general practitioners, and 500 private practices, alongside an audit team with experience across 450+ audits and 160+ trials.

CTC is part of a European CRO network providing cross-border execution across 17+ countries including Bulgaria, Hungary, Germany, Poland, UK, Serbia, Moldova, Austria, Czech Republic, Slovakia, Russia, Ukraine, Spain, Slovenia, Croatia, Montenegro, and Bosnia and Herzegovina. The business model is professional services, quote-based, and tailored to each sponsor protocol, with revenue derived from enterprise B2B contracts rather than transactional pricing. CTC reports a clinical research team turnover below 12.5% and average team experience exceeding 10.33 years, and has supported trials leading to FDA and EMA marketing authorizations including Gilenya (multiple sclerosis) and Galvus (diabetes).

Name

Clinical Trial Center

Legal name

Clinical Trial Center

Website

https://clinicaltrial.ro

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Short description

Clinical Trial Center is an independent, full-service Contract Research Organization founded in 2005 in Timisoara, Romania, providing clinical trial services including monitoring, regulatory affairs, auditing, and data management to international pharmaceutical, medical devices, and biotechnology sponsors across Romania and 17+ European countries.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) / Clinical Trial Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Clinical Trial Site Operations & Study Coordination (HLAGACAE), Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG)

Keywords

• Clinical trial services
• Contract research organization
• Clinical monitoring services
• Regulatory affairs services
• Clinical data management

Headquarters

HQ city

Timisoara

HQ country

Romania

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Clinical Research Services: Full-service CRO providing clinical trial services including project management, monitoring, regulatory affairs, training, data management, biometrics, and auditing to pharmaceutical, medical devices and biotechnology companies.

Go-to-market motion1 record

Distribution channels1 record

Core offering

Clinical Trial Center is an independent, full-service Contract Research Organization (CRO) providing clinical trial services to pharmaceutical, medical devices, and biotechnology companies. Offerings span project management, GCP training, investigator meeting organization, flying nurse services, clinical monitoring, regulatory affairs, auditing, biometrics/medical biostatistics, data management, and certified translations. Services are delivered by pharmacists and medical doctors using ICH-GCP, EU Directives, and FDA regulatory frameworks, with national coverage in Romania and European reach via a CRO network.

Product overview

Clinical Trial Center is an independent full-service Contract Research Organization (CRO) providing clinical trial related services to pharmaceutical, medical devices and biotechnology companies. The company operates a modular service architecture comprising Project Management, GCP Training, Investigator Meeting Organization, Flying Nurse Services, Clinical Monitoring, Regulatory Affairs, Auditing Services, Biometrics and Medical Biostatics, Data Management, and Certified Translations. Services are delivered by a team of pharmacists and medical doctors, supported by a national network of investigators across multiple therapeutic areas including Pneumology, Cardiology, Nephrology, Neurology, Diabetes and Metabolic Diseases, Endocrinology, Rheumatology, Infectious Diseases, Obstetrics and Gynecology, Oncology, and Dermatology. The company conducts Phase I, Phase II, Phase III, and non-interventional clinical trials.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Over 150 clinical trials conducted in 15 years
• +4 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• European CRO NetworkcoreStrategic or Co-development PartnerCTC is part of a European CRO network providing European presence across Bulgaria, Hungary, Germany, Poland, UK, Serbia, Republic of Moldavia, Austria, Czech Republic, Slovakia, Russia, Ukraine, Spain, Slovenia, Croatia, Montenegro, Bosnia and Herzegovina. This network enables multinational clinical trial execution.

Scale indicators8 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Parexel: Large global full-service CRO serving pharma and biotech across Phase I–IV. Comparable as a broad incumbent competing for the same multinational trial work, though at substantially greater scale and geographic reach than CTC.
• PPD (Thermo Fisher Scientific): Major global CRO now part of Thermo Fisher's clinical research division, offering full-service clinical development. A broad incumbent competitor whose size and technology stack represent the long-term consolidation threat to mid-tier CROs like CTC.
• IQVIA: Largest global CRO with integrated technology, data, and consulting capabilities. Comparable as the dominant incumbent sponsor-side CRO whose scale and technology investment set the competitive benchmark against which CTC must differentiate.
• Syneos Health: Large biopharmaceutical services organization combining clinical CRO with commercial/launch capabilities. A broad incumbent peer competing for the same multinational sponsor mandates, though with a portfolio and scale far beyond CTC.
• ICON plc: One of the largest global CROs offering end-to-end clinical development, laboratory, and consulting services. A relevant incumbent comparable because it competes for the same multinational sponsor RFPs, but operates at materially greater scale and breadth than CTC.
• Charles River Laboratories: Large CRO/preclinical services provider with growing clinical footprint via the Retrogenix and Cognate acquisitions. Relevant incumbent comparable on the clinical services side, though with a much broader discovery-to-commercial platform.

Direct peers

• Medpace: Mid-size, full-service global CRO with a reputation for operational focus and therapeutic specialization across Phase I–III. Medpace is a useful comparable because it scaled from a similar boutique operating model and now competes for many of the same mid-size sponsor programs CTC targets.
• Worldwide Clinical Trials: Mid-size global CRO offering Phase I–IV clinical development across multiple therapeutic areas. Directly comparable to CTC on full-service delivery, mid-tier scale, and reliance on sponsor relationships rather than sheer volume.
• Premier Research: Mid-size CRO focused on biotech and specialty pharma sponsors, with strengths in rare disease and complex trial design. Comparable to CTC's biotech/medical device customer mix and full-service operating model.
• Ergomed: Smaller full-service CRO with strong pharmacovigilance and clinical research services, historically serving mid-size European sponsors. Comparable to CTC on scale, European footprint, and pharma/biotech sponsor base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/clinical-trial-center-tm

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clinical Trial Center